Associated Papers
Super-enhancer hijacking drives ectopic expression of hedgehog pathway ligands in meningiomas.
Youngblood MW et al.
Nature Communications, 2023
37805627 (PubMed )
Supplement: 41467_2023_41926_MOESM3_ESM.xlsx › SD1
Clinical utility of Todai OncoPanel in the setting of approved comprehensive cancer genomic profiling tests in Japan.
Kage H et al.
Cancer Science, 2023
36601953 (PubMed )
Supplement: CAS-114-1710-s001.xlsx › Sup_Table_3
Differential NF2 Gene Status in Sporadic Vestibular Schwannomas and its Prognostic Impact on Tumour Growth Patterns.
Chen H et al.
Scientific Reports, 2017
28710469 (PubMed )
Supplement: 41598_2017_5769_MOESM2_ESM.xlsx › Table_S1
Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets.
Chen YB et al.
Nature Communications, 2016
27713405 (PubMed )
Supplement: ncomms13131-s3.xlsx › All_mutations
SMARCB1 involvement in the development of leiomyoma in a patient with schwannomatosis.
Hulsebos TJ et al.
The American Journal of Surgical Pathology, 2014
Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO.
Clark VE et al.
Science (new York, N.y.), 2013
Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations.
Evans DG et al.
Journal of Medical Genetics, 1998
Select a paper to view details